CA3121743A1 — Processes for preparing jak inhibitors and related intermediate compounds
Assigned to Incyte Holdings Corp · Expires 2010-07-22 · 16y expired
What this patent protects
The present invention is related to processes for preparing chiral substituted pyrazolyl pyrrolo[2,3-d]pyrimidines of Formula la and Formula III. The compounds are useful as inhibitors of the Janus Kinase family or protein tyrosine kinases (JAKs) and for treatment of…
USPTO Abstract
The present invention is related to processes for preparing chiral substituted pyrazolyl pyrrolo[2,3-d]pyrimidines of Formula la and Formula III. The compounds are useful as inhibitors of the Janus Kinase family or protein tyrosine kinases (JAKs) and for treatment of inflammatory diseases, myeloproliferative diseases, and other disorders.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.